R-COMP

not specified · not specified

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R-COMP, covering 2024-02-26 to 2024-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb [Phase 2]

See pricing